Salvatore Ferragamo S.p.A. (OTCMKTS:SFRGY – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 4,850 shares, an increase of 77.5% from the September 30th total of 2,732 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 1,696 shares, the days-to-cover ratio is presently 2.9 days.
Analyst Ratings Changes
Separately, Citigroup restated a “neutral” rating on shares of Salvatore Ferragamo in a research note on Monday, August 17th. Two research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company has a consensus rating of “Hold”.
Check Out Our Latest Research Report on SFRGY
Salvatore Ferragamo Price Performance
Shares of Salvatore Ferragamo stock traded up $0.11 during midday trading on Monday, reaching $3.52. 1,220 shares of the company’s stock traded hands, compared to its average volume of 8,713. The stock has a 50 day moving average of $4.42 and a 200-day moving average of $4.71. Salvatore Ferragamo has a 12 month low of $3.34 and a 12 month high of $6.72.
Salvatore Ferragamo Company Profile
Salvatore Ferragamo S.p.A. is an Italian luxury-goods company best known for its footwear and leather craftsmanship. The company designs and sells luxury shoes, handbags, small leather goods, apparel, silk products, accessories, eyewear, watches and fragrances under the Ferragamo brand.
The company traces its origins to Salvatore Ferragamo, who established his business in Italy in 1927 after developing a reputation as a footwear designer in the United States. Ferragamo became known for combining technical innovation with Italian craftsmanship, and the business later expanded from shoes into a broader lifestyle and luxury-fashion offering.
Salvatore Ferragamo serves customers internationally through directly operated stores, e-commerce, selected wholesale partners and travel-retail locations.
See Also
- Five stocks we like better than Salvatore Ferragamo
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Salvatore Ferragamo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Salvatore Ferragamo and related companies with MarketBeat.com's FREE daily email newsletter.
